CSL SeqirusWaltham, Massachusetts, United States
Disclosure(s): CSL Seqirus: Employee, Stocks/Bonds (Public Company)
164 - Effectiveness of Adjuvanted Inactivated Influenza Vaccine versus High-Dose Inactivated Influenza Vaccine Against PCR-Confirmed Influenza among Adults ≥65 years: A Pragmatic Randomized Study
Thursday, October 17, 20241:45 PM – 1:57 PM US PT